Feedback / Questions
Anktiva (nogapendekin alfa inbakicept-pmln) - ImmunityBio
https://www.businesswire.com/news/home/20250826147574/en/Initial-Data-Shows-100-Disease-Control-in-5-Out-of-5-Patients-With-Recurrent-Glioblastoma-With-Two-Patients-in-Near-Complete-Response-Treated-With-ImmunityBios-ANKTIVA-NK-Cell-Therapy-Plus-Optune-Gio-Device
Aug 26, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next